GERHARD KOENIG
Pilots at Commonwealth Ave, Newton, MA
License number
Massachusetts A5152124
Issued Date
Oct 2015
Expiration Date
Oct 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
1662 Commonwealth Ave, Newton, MA 02465
Personal information
See more information about GERHARD KOENIG at radaris.comName
Address
Phone
1662 Commonwealth Ave, Newton, MA 02465
Professional information
See more information about GERHARD KOENIG at trustoria.com
Treatment Of Inflammation With Certain Alpha-7 Nicotinic Acid Receptor Agonists In Combination With Acetylcholinesterase Inhibitors
Treatment Of Inflammation With Certain Alpha-7 Nicotinic Acid Receptor Agonists In Combination With Acetylcholinesterase Inhibitors
US Patent:
2013023, Sep 5, 2013
Filed:
Nov 18, 2011
Appl. No.:
13/988205
Inventors:
Gerhard Koenig - Newton MA, US
International Classification:
A61K 31/439, A61K 45/06
US Classification:
514305
Abstract:
A method for treating inflammation comprising administering to a patient (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof or (R)-7-(2-methoxyphenyl)-N-(quinuclidin-3-yl)benzofuran-2-carboxamide or certain other alpha 7 receptor agonists combination with an acetylcholinesterase inhibitor.
Treatment Of Cognitive Disorders With Certain Alpha-7 Nicotinic Acid Receptor Agonists In Combination With Acetylcholinesterase Inhibitors
Treatment Of Cognitive Disorders With Certain Alpha-7 Nicotinic Acid Receptor Agonists In Combination With Acetylcholinesterase Inhibitors
US Patent:
2013022, Aug 29, 2013
Filed:
Jul 25, 2011
Appl. No.:
13/812260
Inventors:
Gerhard Koenig - Newton MA, US
Dana Hilt - Waltham MA, US
Dana Hilt - Waltham MA, US
Assignee:
ENVIVO PHARMACEUTICALS, INC. - Watertown MA
International Classification:
A61K 31/439, A61K 31/501, A61K 31/55, A61K 31/473, A61K 31/325, A61K 31/444, A61K 31/445
US Classification:
514215, 514305, 51425204, 514297
Abstract:
A method for improving cognition comprising administering to a patient certain alpha-7 receptor agonists and an acetylcholinesterase inhibitor is described together with related compositions.
Treatment Of Cognitive Disorders With Certain Alpha-7 Nicotinic Acid Receptors In Combination With Acetylcholinesterase Inhibitors
Treatment Of Cognitive Disorders With Certain Alpha-7 Nicotinic Acid Receptors In Combination With Acetylcholinesterase Inhibitors
US Patent:
2011012, May 26, 2011
Filed:
Dec 27, 2010
Appl. No.:
12/979139
Inventors:
Gerhard Koenig - Newton MA, US
Dana Hilt - Waltham MA, US
Dana Hilt - Waltham MA, US
International Classification:
A61K 31/439, A61K 31/473, A61K 31/55, A61P 25/00, A61P 25/28
US Classification:
514215, 514305, 514297
Abstract:
A method for improving cognition comprising administering to a patient (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide or a pharmaceutically acceptable salt thereof and an acetylcholinesterase inhibitor is described together with related compositions.
Treatment Of Cognitive Disorders With (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide And Pharmaceutically Acceptable Salts Thereof
Treatment Of Cognitive Disorders With (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide And Pharmaceutically Acceptable Salts Thereof
US Patent:
8569354, Oct 29, 2013
Filed:
Nov 12, 2012
Appl. No.:
13/674290
Inventors:
Gideon Shapiro - Gainesville FL, US
Gerhard Koenig - Newton MA, US
Gerhard Koenig - Newton MA, US
Assignee:
EnVivo Pharmaceuticals, Inc. - Watertown MA
International Classification:
A61K 31/403, C07D 487/02
US Classification:
514412, 548453
Abstract:
(R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide has been found to have procognitive effects in humans at unexpectedly low doses. Thus, (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof can be used at unexpectedly low doses to improve cognition.
Treatment Of Cognitive Disorders With (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide And Pharmaceutically Acceptable Salts Thereof
Treatment Of Cognitive Disorders With (R)-7-Chloro-N-(Quinuclidin-3-Yl)Benzo[B]Thiophene-2-Carboxamide And Pharmaceutically Acceptable Salts Thereof
US Patent:
8642638, Feb 4, 2014
Filed:
Nov 19, 2009
Appl. No.:
13/129782
Inventors:
Richard Chesworth - Boston MA, US
Gideon Shapiro - Gainesville FL, US
Gerhard Koenig - Newton MA, US
Gideon Shapiro - Gainesville FL, US
Gerhard Koenig - Newton MA, US
Assignee:
EnVivo Pharmaceuticals, Inc. - Watertown MA
International Classification:
A61K 31/403, C07D 487/02
US Classification:
514412, 548453
Abstract:
(R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide has been found to have procognitive effects in humans at unexpectedly low doses. Thus, (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof can be used at unexpectedly low doses improve cognition.